CCM Concord Medical Services Holdings Ltd Annual reports only
Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1472072 · Reporting currency CNY
Financial factors as of 2018-12-31 (FY2018), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · CNY | FY20242024-12-31 · USD |
|---|---|---|
| Income statement | ||
| Revenue | 460.51M | $52.60M |
| Cost of revenue | 434.69M | $63.45M |
| Gross profit | 25.82M | -$10.85M |
| SG&A expense | 212.97M | $55.40M |
| Operating income | -261.49M | -$72.91M |
| Interest expense | 152.33M | $26.47M |
| Pretax income | -373.36M | -$91.73M |
| Income tax | 6.06M | -$2.40M |
| Net income | -92.81M | -$42.23M |
| EBITDA | -157.98M | -$61.29M |
| EPS (basic) | -0.71 | -0.32 |
| EPS (diluted) | -0.71 | -0.32 |
| Weighted avg. shares (diluted) | 131.05M | 131.05M |
| Balance sheet | ||
| Cash & equivalents | 297.79M | $33.89M |
| Short-term investments | 1,000 | $18.44M |
| Receivables | 44.05M | $7.01M |
| Inventory | 45.97M | $4.58M |
| Current assets | 941.91M | $134.80M |
| PP&E, net | 3.72B | $507.49M |
| Goodwill | 572.22M | $81.83M |
| Intangibles | 255.91M | $40.02M |
| Total assets | 6.55B | $921.51M |
| Current liabilities | 1.95B | $291.17M |
| Short-term debt | 981.06M | $141.48M |
| Long-term debt | 2.47B | $369.03M |
| Total debt | 3.45B | $510.51M |
| Total liabilities | 4.70B | $699.88M |
| Shareholders' equity | -2.10B | -$312.41M |
| Net debt | 3.15B | $476.62M |
| Cash flow statement | ||
| Operating cash flow | -201.82M | -$54.49M |
| Capital expenditure | 56.32M | $20.66M |
| Free cash flow | -258.15M | -$75.15M |
| Investing cash flow | 53.97M | -$81.30M |
| Financing cash flow | 197.23M | $157.00M |
| Depreciation & amortization | 103.51M | $11.61M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.